Skip to Content

COVID-19 May Increase Risk for Adverse Pregnancy Outcomes

MONDAY, March 22, 2021 -- COVID-19 is associated with increased risks for preeclampsia, preterm birth, and other adverse pregnancy outcomes, according to a review published online March 19 in CMAJ, the journal of the Canadian Medical Association.

Shu Qin Wei, M.D., Ph.D., from the Université de Montréal, and colleagues conducted a systematic literature review and meta-analysis of data from studies (through Jan. 29, 2021) evaluating the severity of COVID-19 infection during pregnancy.

Based on 42 studies (438,548 pregnant women), the researchers found that COVID-19 was associated with preeclampsia (odds ratio [OR], 1.33), preterm birth (OR, 1.82), and stillbirth (OR, 2.11) compared with women with no severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy. Severe COVID-19 was strongly associated with preeclampsia (OR, 4.16), preterm birth (OR, 4.29), gestational diabetes (OR, 1.99), and low birth weight (OR, 1.89) compared with mild SARS-CoV-2 infection.

"Clinicians should be aware of these adverse outcomes when managing pregnancies in patients with COVID-19 and adopt effective strategies to prevent or reduce risks to patients and fetuses," the authors write.

Abstract/Full Text (subscription or payment may be required)

© 2021 HealthDay. All rights reserved.

Read this next

Grandmaternal DDT Exposure Tied to Granddaughter Early Menarche, Obesity

FRIDAY, April 16, 2021 -- Grandmaternal perinatal serum dichlorodiphenyltrichloroethane (DDT) is associated with granddaughter adult obesity and early menarche, according to a...

Response to One COVID-19 Vaccine Dose Strong in Previously Infected

FRIDAY, April 16, 2021 -- For persons with a history of previous infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the neutralizing antibody titer is...

Booster Shots a Likely Reality for COVID-19-Vaccinated Americans

FRIDAY, April 16, 2021 -- Vaccinated Americans will probably need booster shots to guard against emerging coronavirus variants in the future, a White House adviser and Pfizer said...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.